ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AHR American Healthcare REIT Inc

14.00
0.15 (1.08%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
American Healthcare REIT Inc NYSE:AHR NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.15 1.08% 14.00 14.01 13.83 13.95 715,744 22:21:41

Anthracite Capital Receives Notice from the NYSE Regarding Non-Compliance with Continued Listing Standard & Announces Intenti...

16/09/2009 10:40pm

Business Wire


American Healthcare REIT (NYSE:AHR)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more American Healthcare REIT Charts.

Anthracite Capital, Inc. (NYSE:AHR) (the “Company” or “Anthracite”) announced today that on September 15, 2009 it received a notice from the New York Stock Exchange (the “NYSE”) that the Company was not in compliance with the NYSE’s continued listing standard that requires that the average closing price of the Company’s common stock be no less than $1.00 per share over a consecutive 30 trading-day period.

The Company intends to bring its average common stock price above $1.00 per share by effecting a reverse stock split, subject to receipt of stockholder approval. In accordance with NYSE rules, the Company will notify the NYSE within 10 business days from the receipt of the notice of its intent to cure the price condition deficiency in this manner.

Under NYSE rules, the Company has six months from the date of the notice to cure the price condition deficiency unless the Company determines that it is necessary to take an action that requires stockholder approval. Since the reverse stock split will require stockholder approval, the notice from the NYSE requires the Company to obtain stockholder approval by no later than its next annual meeting of stockholders. The Company’s 2010 Annual Meeting of Stockholders is scheduled on May 18, 2010. The Company must implement the reverse stock split promptly thereafter. If the Company has not cured the price condition deficiency by that date, its common stock will be subject to suspension and delisting by the NYSE. The price condition deficiency will be deemed cured if the Company’s common stock price then promptly exceeds $1.00 per share and remains above $1.00 for the following 30 trading days.

The ratio of the reverse stock split will be determined based on the facts and circumstances at a later date.

The Company’s common stock will continue to be listed on the NYSE under the symbol “AHR” during this interim cure period, but will be assigned a “.BC” indicator by the NYSE to signify that the Company is not currently in compliance with the NYSE’s quantitative continued listing standards. The Company’s continued listing during this interim cure period is also subject to the Company’s compliance with other NYSE requirements and the NYSE’s right to reevaluate continued listing determinations, including if the Company’s common stock trades at levels viewed to be abnormally low over a sustained period of time.

About Anthracite

Anthracite Capital, Inc. is a specialty finance company focused on investments in high yield commercial real estate loans and related securities. Anthracite is externally managed by BlackRock Financial Management, Inc., which is a subsidiary of BlackRock, Inc. (“BlackRock”) (NYSE:BLK), one of the largest publicly traded investment management firms in the United States with approximately $1.373 trillion in global assets under management at June 30, 2009. BlackRock Realty Advisors, Inc., another subsidiary of BlackRock, provides real estate equity and other real estate-related products and services in a variety of strategies to meet the needs of institutional investors.

Forward-Looking Statements

This release, and other statements that Anthracite may make, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, with respect to Anthracite’s future financial or business performance, strategies or expectations. Forward-looking statements are typically identified by words or phrases such as “trend,” “potential,” “opportunity,” “pipeline,” “believe,” “comfortable,” “expect,” “anticipate,” “current,” “intention,” “estimate,” “position,” “assume,” “outlook,” “continue,” “remain,” “maintain,” “sustain,” “seek,” “achieve,” and similar expressions, or future or conditional verbs such as “will,” “would,” “should,” “could,” “may” or similar expressions.

Anthracite cautions that forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and Anthracite assumes no duty to and does not undertake to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements and future results could differ materially from historical performance.

In addition to factors previously disclosed in Anthracite’s SEC reports and those identified elsewhere in this release, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance: (1) the introduction, withdrawal, success and timing of business initiatives and strategies; (2) changes in political, economic or industry conditions, the interest rate environment, financial and capital markets or otherwise, which could result in changes in the value of the Company’s assets and liabilities, including net realized and unrealized gains or losses, and could adversely affect the Company’s operating results; (3) the Company’s ability to meet its liquidity requirements to continue to fund its business operations, including its ability to renew its existing facilities or obtain replacement financing, to meet amortization payments under the facilities and to service debt; (4) the amount and timing of any future margin calls and their impact on the Company’s financial condition and liquidity; (5) the Company’s ability to obtain amendments and waivers in the event that a lender terminates a facility before the maturity date or debt obligations are accelerated due to a covenant breach or otherwise; (6) the relative and absolute investment performance and operations of BlackRock Financial Management, Inc. (the ‘‘Manager’’), the Company’s Manager; (7) the impact of increased competition; (8) the impact of future acquisitions or divestitures; (9) the unfavorable resolution of legal proceedings; (10) the impact of legislative and regulatory actions and reforms and regulatory, supervisory or enforcement actions of government agencies relating to the Company or the Manager; (11) terrorist activities and international hostilities, which may adversely affect the general economy, domestic and global financial and capital markets, specific industries, and the Company; (12) the ability of the Manager to attract and retain highly talented professionals; (13) fluctuations in foreign currency exchange rates; (14) the impact of changes to tax legislation and, generally, the tax position of the Company; and (15) as a result of its liquidity position, current market conditions and the uncertainty relating to its ability to meet covenants in restructured agreements, substantial doubt about the Company’s ability to continue as a going concern.

Anthracite’s Annual Report on Form 10-K for the year ended December 31, 2008 and Anthracite’s subsequent filings with the SEC, accessible on the SEC’s website at www.sec.gov, identify additional factors that can affect forward-looking statements.

1 Year American Healthcare REIT Chart

1 Year American Healthcare REIT Chart

1 Month American Healthcare REIT Chart

1 Month American Healthcare REIT Chart

Your Recent History

Delayed Upgrade Clock